GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Policy Acquisition Expense

Celltrion (XKRX:068270) Policy Acquisition Expense


View and export this data going back to 2005. Start your Free Trial

What is Celltrion Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Celltrion (XKRX:068270) Business Description

Traded in Other Exchanges
N/A
Address
13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.